Explorer les evidences

3,7 %A selection rate of 3.7% (1 out of 27) of resistance mutations was observed in drug-naive HIV-HBV-coinfected patients in southwestern Nigeria.

Nigeriahépatite B · VIH/sidapublié 2019Antiviral therapyPubMeddocument de 4 observations

5 %In 2019, the hepatitis B virus (HBV) positivity rate among screened pregnant women in Nigeria was 5%.

Nigeriahépatite Bobservé 2019publié 2021International journal of STD & AIDSPubMeddocument de 10 observations

2,1 %The overall yield of hepatitis B surface antigen (HBsAg) in this intervention was 2.1%.

NigeriaHBsAg · hépatite Bobservé 2017publié 2022West African journal of medicinePubMeddocument de 14 observations

19 %In 2019, the hepatitis B virus (HBV) screening rate among pregnant women in the South West zone of Nigeria was 19%.

Nigeriahépatite Bobservé 2019publié 2021International journal of STD & AIDSPubMeddocument de 10 observations

Significant increases in total protein and gamma globulin but a reduction in albumin concentrations were observed in the HIV/HBV co-infected group.

Nigeriahépatite B · VIH/sidapublié 2022African health sciencesPubMeddocument de 3 observations

14 %Hepatitis B testing increased from 14% at baseline to 55% at 6-month follow-up among youth participants.

Nigeriahépatite Bpublié 2022AIDS patient care and STDsPubMeddocument de 7 observations

Significant increases in the glucogenic, aromatic and branched-chain amino acid concentrations were observed in the HIV/HBV co-infected subjects.

Nigeriahépatite B · VIH/sidapublié 2022African health sciencesPubMeddocument de 3 observations

12,4 %HBV-DNA was detected in 12.4% of 410 individuals in Osun and Ekiti states, southwest Nigeria, between 2019 and 2021.

Nigeriahépatite Bobservé 2019 and 2021publié 2023Viruseseurope_pmcdocument de 6 observationsDOI 10.3390/v15112188

6,6 %The 95% confidence interval for the prevalence of HBsAg positivity among pregnant women in Jos, Nigeria was 6.6% to 8.4%.

Nigeriahépatite Bobservé November 1, 2017 to April 30, 2018publié 2020Annals of African medicinePubMeddocument de 5 observations

8,5 %In 2019, the hepatitis B virus (HBV) positivity rate among screened pregnant women in the North Central zone of Nigeria was 8.5%.

Nigeriahépatite Bobservé 2019publié 2021International journal of STD & AIDSPubMeddocument de 10 observations

12,7 %The proportion with HBV was 12.7% among those with multiple sexual partners.

Nigeriahépatite Bpublié 2022Journal of immunoassay & immunochemistryeurope_pmcdocument de 5 observations

2,8 %Lower HDV prevalence was observed in the Southeast (2.8%) among HBV-infected individuals in Nigeria.

Nigeriahépatite B · hepatitis D viruspublié 2024VirusesPubMeddocument de 7 observations

5 percent_range_lowerAmong people living with HIV in Sub-Saharan Africa, 5–20% are co-infected with Hepatitis B virus.

Nigeriahépatite B · VIH/sidapublié 2020PloS onePubMeddocument de 4 observations

0,11 %Among 2775 pregnant women in Nigeria, the seroprevalence of HBV-HCV dual infection was 0.11%.

Nigeriahépatite B · hépatite Cpublié 2025Antiviral therapyPubMeddocument de 7 observations

0,4 %Immune escape HBV variants were detected in 0.4% of cases.

Nigeriahépatite Bobservé 2018publié 2025Pathogens (Basel, Switzerland)PubMeddocument de 8 observations

7,5 %Of the 200 participants, 15 (7.5%) were HBsAg-positive.

Nigeriahépatite Bpublié 2022Journal of immunoassay & immunochemistryPubMeddocument de 5 observations

6,7 %The prevalence of anti-HBc among 150 PLHIV in the study was 6.7%.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

32,2 %HBV drug resistance mutations (V173L, L180M, S202I and M204V/I) were detected in 32.2% (10/31) of HBV DNA-positive samples.

Nigeriahépatite Bobservé June 2017 to August 2017publié 2021Virology journalPubMeddocument de 6 observations

10,3 %The prevalence of HBV among HIV-infected women of reproductive age in Benue State, Nigeria was 10.3%.

Nigeriahépatite B · VIH/sidapublié 2020PloS onePubMeddocument de 4 observations

Triple infection with HIV/HBV/HDV was associated with significantly lower CD4+ cell counts and worse clinical outcomes, including elevated liver enzymes and rapid progression to liver cancer.

Nigeriahépatite B · hepatitis D virus · VIH/sidapublié 2024VirusesPubMeddocument de 7 observations

98,4 %The predominant circulating HBV genotype in Nigeria was E, found in 98.4% of cases.

Nigeriahépatite Bobservé 2018publié 2025Pathogens (Basel, Switzerland)PubMeddocument de 8 observations

5,6 %Among 36 HBV-DNA positive samples, 5.6% (2/36) had anti-HDV total antibodies.

Nigeriahépatite B · Hepatitis Dobservé June 2017 to August 2017publié 2021Virology journalPubMeddocument de 6 observations

11,8 %Among PLHIV aged 51–60 years, the prevalence of anti-HBe was 11.8%.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

7,4 %Potential drug resistance mutations were observed in 7.4% (2 out of 27) of HBV-monoinfected patients in southwestern Nigeria.

Nigeriahépatite Bpublié 2019Antiviral therapyPubMeddocument de 4 observations

Significant increases in alpha-1 and alpha-2 globulin concentrations were observed in the mono- and co-infected groups compared to the seronegative control group.

Nigeriahépatite B · VIH/sidapublié 2022African health sciencesPubMeddocument de 3 observations